New York, NY, United States of America

XiaoXia Qian


 

Average Co-Inventor Count = 7.8

ph-index = 5

Forward Citations = 71(Granted Patents)


Company Filing History:


Years Active: 2001-2019

Loading Chart...
Loading Chart...
23 patents (USPTO):

Title: Innovations and Contributions of XiaoXia Qian

Introduction

XiaoXia Qian, based in New York, NY, is an accomplished inventor with a portfolio of 23 patents. His work primarily focuses on therapeutic agents aimed at treating a variety of neurological and psychiatric disorders. Throughout his career, he has made significant contributions to the field of medicinal chemistry.

Latest Patents

Among Qian's latest patents are the following innovations:

1. **Pyrimidinone Amide Compounds as PDE2 Inhibitors**: This invention involves pyrimidinone amide compounds that show promise as therapeutic agents for central nervous system and peripheral disorders linked to phosphodiesterase 2 (PDE2). These compounds are designed to treat various neurological and psychiatric conditions, including schizophrenia, psychosis, Alzheimer's disease, cognitive impairment, anxiety, depression, migraines, Huntington's disease, Parkinson's disease, and Parkinson's disease dementia (PDD).

2. **Azabenzimidazole Tetrahydrofuran Derivatives**: This patent details the development of novel compounds that act as activators of AMP-protein kinase. These compounds may be beneficial in treating, preventing, and managing diseases related to the activation of AMPK. They target conditions like Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.

Career Highlights

XiaoXia Qian has a rich history in pharmaceutical research, having worked with globally recognized companies such as Merck Sharp & Dohme Corporation and Merck & Company, Inc. His expertise in the field has garnered him numerous patents and respect among his peers.

Collaborations

Throughout his career, Qian has collaborated with distinguished colleagues, including Tesfaye Biftu and Danqing D Feng. These partnerships have enhanced the innovative research methodologies and outcomes of their projects.

Conclusion

XiaoXia Qian is a notable innovator whose work has the potential to transform treatment approaches for numerous debilitating conditions. His extensive patent portfolio highlights his commitment to advancing medical science and improving patient outcomes through groundbreaking pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…